BR112017014017A2 - sistemas e métodos para distribuição melhorada de moléculas osteoindutoras em reparo ósseo. - Google Patents

sistemas e métodos para distribuição melhorada de moléculas osteoindutoras em reparo ósseo.

Info

Publication number
BR112017014017A2
BR112017014017A2 BR112017014017A BR112017014017A BR112017014017A2 BR 112017014017 A2 BR112017014017 A2 BR 112017014017A2 BR 112017014017 A BR112017014017 A BR 112017014017A BR 112017014017 A BR112017014017 A BR 112017014017A BR 112017014017 A2 BR112017014017 A2 BR 112017014017A2
Authority
BR
Brazil
Prior art keywords
systems
methods
bone repair
improved distribution
osteoinductive
Prior art date
Application number
BR112017014017A
Other languages
English (en)
Inventor
Brown Christopher
g wilson Christopher
J Vanderploeg Eric
Seeherman Howard
Kambouris John
Wozney John
Original Assignee
Bioventus Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioventus Llc filed Critical Bioventus Llc
Publication of BR112017014017A2 publication Critical patent/BR112017014017A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0036—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • A61L24/0084—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing fillers of phosphorus-containing inorganic compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Composite Materials (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Oxide Ceramics (AREA)

Abstract

são oferecidos sistemas e métodos para preparar enxertos ósseos osteoindutores nos quais um grânulo de cerâmica porosa, que pode ser incorporado em um material matricial biocompatível, é carregado com um agente osteoindutor. o carregamento de grânulos, em alguns casos, é facilitado pelo uso de tampões de ph baixo e pré-tratamentos.
BR112017014017A 2014-12-29 2015-12-29 sistemas e métodos para distribuição melhorada de moléculas osteoindutoras em reparo ósseo. BR112017014017A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462097363P 2014-12-29 2014-12-29
US201562144276P 2015-04-07 2015-04-07
US201562182301P 2015-06-19 2015-06-19
PCT/US2015/067891 WO2016109555A1 (en) 2014-12-29 2015-12-29 Systems and methods for improved delivery of osteoinductive molecules in bone repair

Publications (1)

Publication Number Publication Date
BR112017014017A2 true BR112017014017A2 (pt) 2018-01-02

Family

ID=55300766

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017014017A BR112017014017A2 (pt) 2014-12-29 2015-12-29 sistemas e métodos para distribuição melhorada de moléculas osteoindutoras em reparo ósseo.

Country Status (10)

Country Link
US (2) US10130678B2 (pt)
EP (1) EP3240563B1 (pt)
JP (1) JP2018500135A (pt)
KR (1) KR20170100634A (pt)
CN (1) CN107847638A (pt)
AU (1) AU2015374114B2 (pt)
BR (1) BR112017014017A2 (pt)
CA (1) CA2977625A1 (pt)
IL (1) IL253157A0 (pt)
WO (1) WO2016109555A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107847638A (zh) * 2014-12-29 2018-03-27 佰欧维恩图斯有限责任公司 用于骨修复中改善骨诱导性分子递送的***和方法
CA3026660A1 (en) * 2016-06-10 2017-12-14 Bioventus, Llc Protein delivery with porous metallic structure
EP3338815A1 (en) * 2016-12-23 2018-06-27 Sunstar Suisse SA Bone graft substitute
US11529438B2 (en) 2018-06-25 2022-12-20 Bioventus, Llc Porous carrier matrix
NL2021794B1 (en) 2018-10-11 2020-05-13 Access2Bone Ip B V Bioactive bone repair particles

Family Cites Families (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394370A (en) * 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US5631142A (en) 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5422340A (en) 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
ATE238417T1 (de) 1991-11-04 2003-05-15 Inst Genetics Llc Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
WO1995011707A1 (en) 1993-10-28 1995-05-04 Thm Biomedical, Inc. Improved process and device for treating and healing a bone void
US7963997B2 (en) 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
US8697108B2 (en) 1994-05-13 2014-04-15 Kensey Nash Corporation Method for making a porous polymeric material
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US6048964A (en) 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
EP1438935A3 (en) 1996-10-23 2005-03-02 SDGI Holdings, Inc. Spinal spacer
JP2000513615A (ja) 1996-12-23 2000-10-17 ドクトル．ハー．ツェー．ロベルト マシーズ スティフツング 骨移植片用生物活性表面層
DE69814352T3 (de) 1997-02-07 2009-08-13 Stryker Corp., Kalamazoo Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
US20010016646A1 (en) 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
DE69803398T2 (de) 1997-10-07 2002-09-26 Robert Mathys Stiftung Bettlac Hydraulischer chirurgischer zement
US6214049B1 (en) 1999-01-14 2001-04-10 Comfort Biomedical, Inc. Method and apparatus for augmentating osteointegration of prosthetic implant devices
EP1102568A1 (en) 1998-08-06 2001-05-30 SDGI Holdings, Inc. Composited intervertebral bone spacers
US6958149B2 (en) 1998-10-06 2005-10-25 Stryker Corporation Repair of larynx, trachea, and other fibrocartilaginous tissues
US6677432B1 (en) 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
US6846906B1 (en) 1998-10-07 2005-01-25 Stryker Corporation Modified proteins of the TGF-β superfamily, including morphogenic proteins
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
US6642285B1 (en) 1999-02-02 2003-11-04 Robert Mathys Stiftung Implant comprising calcium cement and hydrophobic liquid
AU770196B2 (en) 1999-02-04 2004-02-12 Warsaw Orthopedic, Inc. Osteogenic paste compositions and uses thereof
EP1150726B1 (en) 1999-02-04 2003-11-05 SDGI Holdings, Inc. Highly-mineralized osteogenic sponge compositions, and uses thereof
TR200102771T2 (tr) 1999-04-01 2002-04-22 Dsm N. V. Kristalleştirme ile elde edilen aglomeralar
US7892532B2 (en) 1999-04-30 2011-02-22 Warsaw Orthopedic, In Emory University Intracellular delivery of osteoinductive proteins and peptides
DK1244388T3 (da) 1999-12-06 2007-05-14 Warsaw Orthopedic Inc Indretning til behandling af mellemhvirvelskiver
DE69909850T2 (de) 1999-12-09 2004-05-27 Dr. H.C. Robert Mathys Stiftung Mit einem magnesiumsalz stabilisierter hydraulischer brushitzement
WO2001047571A2 (en) 1999-12-29 2001-07-05 Regeneration Technologies, Inc. System for reconstituting pastes and methods of using same
KR100761184B1 (ko) 2000-04-20 2007-10-04 디에스엠 아이피 어셋츠 비.브이. 경화성 수지 조성물, 경화 필름 및 복합 제품
US20020022885A1 (en) * 2000-05-19 2002-02-21 Takahiro Ochi Biomaterial
US7156860B2 (en) 2000-05-26 2007-01-02 Wallsten Medical S.A. Balloon catheter
AU2001274821A1 (en) 2000-06-13 2001-12-24 Gary K. Michelson Manufactured major long bone ring implant shaped to conform to a prepared intervertebral implantation space
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US7504374B2 (en) 2000-10-24 2009-03-17 Warsaw Orthopedic, Inc. Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of LMP-1 and BMP-2
AU2002225862B2 (en) 2000-10-24 2005-05-12 Warsaw Orthopedic, Inc. Spinal fusion methods and devices
CA2365376C (en) 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
AT4928U1 (de) 2001-03-29 2002-01-25 Plansee Tizit Ag Verfahren zur herstellung eines hartmetallansatzes
US6749636B2 (en) 2001-04-02 2004-06-15 Gary K. Michelson Contoured spinal fusion implants made of bone or a bone composite material
US6989031B2 (en) 2001-04-02 2006-01-24 Sdgi Holdings, Inc. Hemi-interbody spinal implant manufactured from a major long bone ring or a bone composite
DK2055267T3 (da) 2001-05-01 2013-07-01 Amedica Corp Strålegennemtrængeligt knogletransplantat
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
EP1344538A1 (en) 2002-03-14 2003-09-17 Degradable Solutions AG Porous biodegradable implant material and method for its fabrication
TW200400062A (en) 2002-04-03 2004-01-01 Mathys Medizinaltechnik Ag Kneadable, pliable bone replacement material
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
RU2005101077A (ru) 2002-06-19 2005-07-10 Др. Х.К. Роберт Матис Стифтунг (Ch) Гидравлический цемент на основе фосфата кальция для применения в хирургии
US7049348B2 (en) 2002-07-06 2006-05-23 Kensey Nash Corporation Resorbable structure for treating and healing of tissue defects
US7313840B2 (en) 2002-07-25 2008-01-01 Charles E. Watkins Induction liquid pump and magnetic tank scrubber
US7744651B2 (en) 2002-09-18 2010-06-29 Warsaw Orthopedic, Inc Compositions and methods for treating intervertebral discs with collagen-based materials
JP4146718B2 (ja) 2002-12-27 2008-09-10 ミライアル株式会社 薄板支持容器
US6974862B2 (en) 2003-06-20 2005-12-13 Kensey Nash Corporation High density fibrous polymers suitable for implant
DE60321328D1 (de) 2003-06-24 2008-07-10 Robert Mathys Foundation Dr H Prothesenvorrichtung zur Wiederherstellung von Knorpel
AU2003257319A1 (en) 2003-08-08 2005-02-25 Biorthex Inc. Biocompatible porous ti-ni material
EP1664168B1 (en) 2003-08-29 2008-12-03 Mayo Foundation for Medical Education and Research Hydrogel porogens for fabricating biodegradable scaffolds
UA88275C2 (ru) 2003-09-12 2009-10-12 Уайет Композиция, которая включает остеогенный белок и фосфат кальция, которая имеет форму твердого штифта, пригодного для внутрикостной инъекции, способ ее получения и применения
JP4540969B2 (ja) * 2003-11-27 2010-09-08 Ｈｏｙａ株式会社 リン酸カルシウムセラミックス多孔体及びその製造方法
EP1537839A1 (en) 2003-12-02 2005-06-08 Dr. h. c. Robert Mathys Foundation Prosthetic device for cartilage repair
US8389588B2 (en) 2003-12-04 2013-03-05 Kensey Nash Corporation Bi-phasic compressed porous reinforcement materials suitable for implant
US8133500B2 (en) 2003-12-04 2012-03-13 Kensey Nash Bvf Technology, Llc Compressed high density fibrous polymers suitable for implant
US7723395B2 (en) 2004-04-29 2010-05-25 Kensey Nash Corporation Compressed porous materials suitable for implant
US7284401B2 (en) 2004-01-12 2007-10-23 Boston Scientific Scimed, Inc. Stent reducing system and device
US20100191292A1 (en) 2004-02-17 2010-07-29 Demeo Joseph Oriented polymer implantable device and process for making same
US8012192B2 (en) 2004-02-18 2011-09-06 Boston Scientific Scimed, Inc. Multi-stent delivery system
US20050186240A1 (en) 2004-02-23 2005-08-25 Ringeisen Timothy A. Gel suitable for implantation and delivery system
US7225518B2 (en) 2004-02-23 2007-06-05 Boston Scientific Scimed, Inc. Apparatus for crimping a stent assembly
AU2004316731B2 (en) 2004-03-08 2010-12-02 Dr.H.C. Robert Mathys Stiftung Hydraulic cement based on calcium phosphate for surgical use
US8137329B2 (en) 2004-03-25 2012-03-20 Medindica-Pak, Inc. Method and apparatus for transforming a delivery container into a waste disposal system
US7749268B2 (en) 2004-05-26 2010-07-06 Warsaw Orthopedic, Inc. Methods for treating the spine
US7722895B1 (en) 2004-09-20 2010-05-25 Warsaw Orthopedic, Inc. Osteogenic implants with combined implant materials, and materials and methods for same
GB0502493D0 (en) 2005-02-07 2005-03-16 Orthogem Ltd Bone cement
US7850656B2 (en) 2005-04-29 2010-12-14 Warsaw Orthopedic, Inc. Devices and methods for delivering medical agents
US8162992B2 (en) 2005-04-30 2012-04-24 Warsaw Orthopedic, Inc. Spinal fusion with osteogenic material and migration barrier
US8092464B2 (en) 2005-04-30 2012-01-10 Warsaw Orthopedic, Inc. Syringe devices and methods useful for delivering osteogenic material
US7910552B2 (en) 2005-05-27 2011-03-22 Bbs-Bioactive Bone Substitutes Oy Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
US8119591B2 (en) 2005-08-01 2012-02-21 Genera Istrazivanja D.O.O. Methods and compositions for regenerating articular cartilage
CN1923752A (zh) * 2005-08-30 2007-03-07 四川大学 一种磷灰石－硅灰石/β－磷酸三钙复合生物活性陶瓷材料
AU2006304730B2 (en) 2005-10-21 2012-09-20 Ada Foundation Dual-phase cement precursor systems for bone repair
AU2005338323B2 (en) 2005-11-15 2011-10-13 Dr.H.C. Robert Mathys Stiftung Bone repair material
US7939092B2 (en) 2006-02-01 2011-05-10 Warsaw Orthopedic, Inc. Cohesive osteogenic putty and materials therefor
US8163018B2 (en) 2006-02-14 2012-04-24 Warsaw Orthopedic, Inc. Treatment of the vertebral column
US20110020419A1 (en) * 2006-02-17 2011-01-27 Huipin Yuan Osteoinductive calcium phosphates
US7598219B2 (en) 2006-02-24 2009-10-06 Warsaw Orthopedic, Inc. Implants comprising an osteoinductive factor and a contrast agent compatible therewith
WO2007097710A1 (en) 2006-02-27 2007-08-30 Agency For Science, Technology And Research Curable bone cement
US7806911B2 (en) 2006-04-14 2010-10-05 Warsaw Orthopedic, Inc. Fixation plate and method of use
US7838022B2 (en) 2006-05-01 2010-11-23 Warsaw Orthopedic, Inc Malleable implants containing demineralized bone matrix
US8506983B2 (en) 2006-05-01 2013-08-13 Warsaw Orthopedic, Inc. Bone filler material
US7833270B2 (en) 2006-05-05 2010-11-16 Warsaw Orthopedic, Inc Implant depots to deliver growth factors to treat osteoporotic bone
US8399619B2 (en) 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
EP2049040B1 (en) 2006-07-21 2015-04-01 GENERA ISTRAZIVANJA d.o.o. Whole blood-derived coagulum device for treating bone defects
US7723291B2 (en) 2006-07-27 2010-05-25 Warsaw Orthopedic, Inc. Release of BMP, bioactive agents and/or cells via a pump into a carrier matrix
GB2440721A (en) 2006-08-11 2008-02-13 Univ Cambridge Tech Composite biomaterial formed by cooling a fluid composition on a porous solid and removing solidified crystals of the liquid carrier
US7671014B2 (en) 2006-08-14 2010-03-02 Warsaw Orthopedic, Inc. Flowable carrier matrix and methods for delivering to a patient
US8524265B2 (en) 2006-08-17 2013-09-03 Warsaw Orthopedic, Inc. Medical implant sheets useful for tissue regeneration
US8449622B2 (en) 2006-09-11 2013-05-28 Warsaw Orthopedic, Inc. Multi-phase osteochondral implantable device
WO2008041846A2 (en) 2006-10-05 2008-04-10 Cam Aesthetics B.V. I.O. Hydroxyapatite tissue filler and its preparation and use
US8388626B2 (en) 2006-11-08 2013-03-05 Warsaw Orthopedic, Inc. Methods of employing calcium phosphate cement compositions and osteoinductive proteins to effect vertebrae interbody fusion absent an interbody device
US8048857B2 (en) 2006-12-19 2011-11-01 Warsaw Orthopedic, Inc. Flowable carrier compositions and methods of use
US8840618B2 (en) 2007-01-12 2014-09-23 Warsaw Orthopedic, Inc. System and method for pressure mixing bone filling material
US8147495B2 (en) 2007-01-16 2012-04-03 Warsaw Orthopedic, Inc. Methods and kits for treating fractures with a biological agent
US8383092B2 (en) 2007-02-16 2013-02-26 Knc Ner Acquisition Sub, Inc. Bioadhesive constructs
US8431148B2 (en) 2007-03-08 2013-04-30 Warsaw Orthopedic, Inc. Bone void filler
US8198237B2 (en) 2007-05-15 2012-06-12 Stryker Corporation Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
US8092452B2 (en) 2007-05-21 2012-01-10 Warsaw Orthopedic, Inc. Percutaneous delivery system for treatment of osteonecrosis of the hip and methods of use thereof
EP2014256A1 (en) 2007-07-12 2009-01-14 Straumann Holding AG Composite bone repair material
US8092541B2 (en) 2007-08-03 2012-01-10 Warsaw Orthopedic, Inc. Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors
DE102007051914A1 (de) * 2007-10-29 2009-05-07 Herbert Prof. Dr. Jennissen Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
US9056150B2 (en) 2007-12-04 2015-06-16 Warsaw Orthopedic, Inc. Compositions for treating bone defects
US20090248162A1 (en) 2008-03-25 2009-10-01 Warsaw Orthopedic, Inc. Microparticle delivery syringe and needle for placing suspensions and removing vehicle fluid
US8840913B2 (en) 2008-03-27 2014-09-23 Warsaw Orthopedic, Inc. Malleable multi-component implants and materials therefor
CA2723128C (en) 2008-05-02 2014-09-30 Dr.H.C. Robert Mathys Stiftung Calcium phosphate particles and hydraulic cements based thereon
US8039433B2 (en) 2008-08-19 2011-10-18 Warsaw Orthopedic, Inc. Osteogenic compositions containing a coloring agent
EP2348835A4 (en) 2008-09-28 2014-01-22 Knc Ner Acquisition Sub Inc MIXES FROM MULTICOLOR CATECHOL COMPOUNDS
WO2010091298A1 (en) 2009-02-06 2010-08-12 Nerites Corporation Multibranched bioadhesive compounds and synthetic methods therefor
JP5841845B2 (ja) 2009-02-24 2016-01-13 ソーク・インステチュート・フォー・バイオロジカル・スタディーズＳａｌｋ Ｉｎｓｔｉｔｕｔｅ Ｆｏｒ Ｂｉｏｌｏｇｉｃａｌ Ｓｔｕｄｉｅｓ ＴＧＦ−βスーパーファミリーのデザイナーリガンド
US7964208B2 (en) 2009-02-25 2011-06-21 Warsaw Orthopedic, Inc. System and methods of maintaining space for augmentation of the alveolar ridge
US8377136B2 (en) 2009-04-20 2013-02-19 Warsaw Orthopedic, Inc. Method for stabilizing an intervertebral disc device
EP2453904A4 (en) 2009-07-15 2014-11-26 Kensey Nash Corp THIN-LAYER COMPOSITIONS AND METHODS FOR THEIR SYNTHESIS AND USE
US8653029B2 (en) 2009-07-30 2014-02-18 Warsaw Orthopedic, Inc. Flowable paste and putty bone void filler
CN102665775A (zh) 2009-10-20 2012-09-12 日东电工株式会社 诱导硬组织再生的材料
AU2010341565A1 (en) 2009-12-22 2012-07-12 Stryker Corporation BMP-7 variants with reduced immunogenicity
US8475824B2 (en) 2010-01-26 2013-07-02 Warsaw Orthopedic, Inc. Resorbable matrix having elongated particles
WO2011109912A1 (en) 2010-03-09 2011-09-15 Mathys Ag Bettlach Bone graft substitute
EP2590605A1 (en) 2010-07-09 2013-05-15 Board of Regents of the University of Texas System Biodegradable scaffolds
WO2012009664A2 (en) 2010-07-16 2012-01-19 Knc Ner Acquisition Sub, Inc. Bioadhesive compounds and methods of synthesis and use
PE20140135A1 (es) 2010-08-20 2014-02-20 Wyeth Llc Proteina osteogenicas de diseno
US20130224277A1 (en) 2010-08-31 2013-08-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation
CA2819258C (en) 2010-12-13 2020-03-10 Biomimetic Therapeutics, Llc Compositions and methods for spine fusion procedures
US8658917B2 (en) 2011-02-04 2014-02-25 Perceptive Pixel Inc. Techniques for disambiguating touch data using user devices
AU2012259434B2 (en) * 2011-02-25 2015-12-17 Synthes Gmbh Osteogenic promoting implants and methods of inducing bone growth
WO2013096650A2 (en) 2011-12-23 2013-06-27 Pioneer Surgical Technology Continuous matrix with osteoconductive particles dispersed therein, method of forming thereof, and method of regenerating bone therewith
EP2836195B1 (en) * 2012-04-11 2021-03-10 Induce Biologics Inc. System and method for multiphasic release of growth factors
US8697107B2 (en) 2012-04-27 2014-04-15 Warsaw Orthopedic, Inc. Flowable implant with crosslinkable surface membrane
US9017417B2 (en) 2012-05-30 2015-04-28 Kensey Nash Bvf Technology Llc Subchondral bone repair system
US20140107593A1 (en) 2012-10-16 2014-04-17 Spinesmith Partners, L.P. Fenestrated needle for delivering therapeutic reagents into soft tissue
CN104127913A (zh) 2013-05-03 2014-11-05 中国科学院上海生命科学研究院 一种骨整合性改良的医用复合材料
CN103357070B (zh) 2013-07-26 2015-05-27 河北工业大学 具有诱导成骨活性的医用β钛合金复合材料及其制备方法
CN103638556B (zh) * 2013-12-03 2016-01-20 四川大学 一种表面纳米化改性磷酸钙生物活性陶瓷及其制备和应用
BR112016030220A2 (pt) * 2014-06-23 2017-11-07 Bioventus Llc método para produzir grânulos porosos de hidroxiapatita deficiente em cálcio
CN104353121A (zh) 2014-11-24 2015-02-18 吴志宏 一种负载bmp微球的3d打印多孔金属支架及其制备方法
CN107847638A (zh) 2014-12-29 2018-03-27 佰欧维恩图斯有限责任公司 用于骨修复中改善骨诱导性分子递送的***和方法

Also Published As

Publication number Publication date
IL253157A0 (en) 2017-08-31
EP3240563A1 (en) 2017-11-08
US20160184390A1 (en) 2016-06-30
US11452760B2 (en) 2022-09-27
CN107847638A (zh) 2018-03-27
CA2977625A1 (en) 2016-07-07
US20190070256A1 (en) 2019-03-07
EP3240563B1 (en) 2020-12-09
WO2016109555A1 (en) 2016-07-07
US10130678B2 (en) 2018-11-20
AU2015374114A1 (en) 2017-08-17
AU2015374114B2 (en) 2018-07-26
KR20170100634A (ko) 2017-09-04
JP2018500135A (ja) 2018-01-11

Similar Documents

Publication Publication Date Title
BR112018008388A2 (pt) composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso
BR112017014017A2 (pt) sistemas e métodos para distribuição melhorada de moléculas osteoindutoras em reparo ósseo.
BR112017022845A2 (pt) neoepítopos de câncer
BR112017011373A2 (pt) método e aparelho para carregamento e implantação de um implante com memória de formato
CR20170234A (es) Composiciones de antibiótico
CL2016000298A1 (es) Compuestos derivados de tieno[2,3-c]piran con actividad moduladora del regulador de la conductancia transmembrana de la fibrosis quistica (cftr); composicion farmaceutica que los comprende; utiles en el tratamiento de la fibrosis quistica.
CL2010001538A1 (es) Compuestos derivados de pirazolo-quinazolina sustituidos, moduladores de la actividad de las proteinas quinasas; composicion farmaceutica; y su uso para el tratamiento del cancer, o un trastorno proliferativo celular.
BR112017005378A2 (pt) composições que compreendem células recombinantes de bacillus e um outro agente de controle biológico.
BR112017018941B8 (pt) Molécula de ligação a cd20, seu uso, composição e método in vitro para direcionar a morte mediada por complemento de uma célula que expressa cd20
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
CL2015002194A1 (es) Inhbidores de erk y sus usos
CL2015001207A1 (es) Composición para prevenir o tratar diabetes, diabesidad o complicaciones diabéticas, que comprende un análogo de oxintomodulina; y uso de la composición.
CA2902714C (en) Bone screws and methods of use thereof
BR112015022625A8 (pt) microarranjo para entrega de agente terapêutico e métodos de utilização
BR112018010381A2 (pt) composições para tratamento de cabelo, condicionadora de cabelo e para alteração da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento de cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos.
BR112017005509A2 (pt) composições que compreendem células recombinantes de bacillus e um outro agente de controle biológico.
EP3441460A4 (en) EX-VIVO EXPANSION PROCEDURE FOR NUCLEAR CELL NUCLEAR BLOODS AND KIT, AND USE THEREOF
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
BR112016016916A8 (pt) uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae)
BR112013018352A2 (pt) composição de minociclina tópica e método
BR112015023003A2 (pt) nucleos de disco intervertebral protético
BR112017009505A2 (pt) composição farmacêutica, e, matriz ou suporte.
BR112014003139A2 (pt) musgo de turfa umectável resistente à lixiviação, método de preparação, e método de uso
EP3704126A4 (en) COMPOUNDS AND THEIR USE IN THE EXPANSION OF STEM CELLS AND / OR PROGENITOR CELLS
CO2020003120A2 (es) Activador akt3 y específico usos de este

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements